Preliminary results of propranolol treatment for patients with infantile hemangioma

Turkish Journal of Pediatrics

Volumn 53, Issue 2, 2011, Pages 137-141

  Çorapcioǧlu, Funda ^a   Büyükkapu Bay, Sema ^a   Binnetoǧlu, Köksal ^a   Babaoǧlu, Abdulkadir ^a   Anik, Yonca ^a   Tugay, Melih ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Hemangioma; Infant; Propranolol

Indexed keywords

GLUCOSE; PREDNISOLONE; PROPRANOLOL;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BRADYCARDIA; CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INFANT; MALE; OUTCOME ASSESSMENT; SHORT COURSE THERAPY; SYSTEMIC THERAPY; TREATMENT DURATION; TUMOR REGRESSION; TUMOR VOLUME; VITAL SIGN;

ADRENERGIC BETA-ANTAGONISTS; COHORT STUDIES; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; PROPRANOLOL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 80052059058     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Garzon MC, Frieden I{ogonek}J. Heamangiomas: when to worry. Pediatr Ann 2000; 29: 58-67.
2. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008; 25: 168-173.
3. Pandey A, Gangopadhyay AN, Gopal SC, et al. Twenty years' experience of steroids in infantile hemangioma-a developing country's perspective. J Pediatr Surg 2009; 44: 688-694.
4. Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Ophthalmol 2009; 24: 178-184.
5. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 326: 1456-1463.
6. Hasan Q, Tan ST, Gush J, Peters SG, Davis PF. Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics 2000; 105: 117-121.
7. Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009; 20: 678-684.
8. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 2009; 26: 642-644.
9. Lawley LP, Siegfried E, Todd JL. Propranolol treatment of infancy: risk and recommendations. Pediatr Dermatol 2009; 26: 610-614.
10. van der Meijs BB, Merks JH, de Haan TR, Tabbers MM, van Rijn RR. Neonatal hepatic haemangioendothelioma: treatment options and dilemmas. Pediatr Radiol 2009; 39: 277-281.
11. Theletsane T, Redfern A, Raynham O, et al. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009; 23: 1465-1466.
12. Léauté-Labréze C, Dumas de la Roque E, Hubiche F, Boralevi F. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
13. Bonifazi E, Colonna V, Mazotta F, et al. Propranolol in rapidly growing hemangiomas. Eur J Pediatr Dermatol 2008; 18: 185-192.
14. Marsciani A, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propranolol. Pediatr Blood Cancer 2010; 54: 176.
15. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423-431.
16. Mousa W, Kues K, Haas E, et al. Successful treatment of large hemangioma with propranolol. J Dtsch Dermatol Ges 2010; 8: 184-186.
17. Robinson RF, Nahata MC, Batisky DL, Mahan JD. Pharmacologic treatment of chronic pediatric hypertension. Paediatr Drugs 2005; 7: 27-40.
18. Yadav S, Khalil A. Propranolol. Indian Pediatr 1989; 26: 811-814.